519 related articles for article (PubMed ID: 8674065)
21. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
[TBL] [Abstract][Full Text] [Related]
22. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
[TBL] [Abstract][Full Text] [Related]
23. The role of CD146 (Mel-CAM) in biology and pathology.
Shih IM
J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
[TBL] [Abstract][Full Text] [Related]
24. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of melanoma precursor lesions.
Wang Y; Rao U; Mascari R; Richards TJ; Panson AJ; Edington HD; Shipe-Spotloe JM; Donnelly SS; Kirkwood JM; Becker D
Cell Growth Differ; 1996 Dec; 7(12):1733-40. PubMed ID: 8959342
[TBL] [Abstract][Full Text] [Related]
26. A malignant melanoma tumor suppressor on human chromosome 11.
Robertson G; Coleman A; Lugo TG
Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
[TBL] [Abstract][Full Text] [Related]
28. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
29. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
[TBL] [Abstract][Full Text] [Related]
30. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
31. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
Herlyn M; Balaban G; Bennicelli J; Guerry D; Halaban R; Herlyn D; Elder DE; Maul GG; Steplewski Z; Nowell PC
J Natl Cancer Inst; 1985 Feb; 74(2):283-9. PubMed ID: 3856042
[TBL] [Abstract][Full Text] [Related]
32. Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype.
Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD; Hiti AL; Gray JW
Oncogene; 1997 Oct; 15(17):2077-91. PubMed ID: 9366525
[TBL] [Abstract][Full Text] [Related]
33. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
[TBL] [Abstract][Full Text] [Related]
34. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
Rummel MM; Sers C; Johnson JP
Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
[TBL] [Abstract][Full Text] [Related]
36. Development of invasive and growth factor-independent cell variants from primary human melanomas.
Kath R; Jambrosic JA; Holland L; Rodeck U; Herlyn M
Cancer Res; 1991 Apr; 51(8):2205-11. PubMed ID: 2009539
[TBL] [Abstract][Full Text] [Related]
37. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
38. Melanoma cell lines from different stages of progression and their biological and molecular analyses.
Satyamoorthy K; DeJesus E; Linnenbach AJ; Kraj B; Kornreich DL; Rendle S; Elder DE; Herlyn M
Melanoma Res; 1997 Aug; 7 Suppl 2():S35-42. PubMed ID: 9578415
[TBL] [Abstract][Full Text] [Related]
39. Functional aspects of three molecules associated with metastasis development in human malignant melanoma.
Johnson JP; Lehmann JM; Stade BG; Rothbächer U; Sers C; Riethmüller G
Invasion Metastasis; 1989; 9(6):338-50. PubMed ID: 2574717
[TBL] [Abstract][Full Text] [Related]
40. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]